119 related articles for article (PubMed ID: 28756979)
1. Thymosin beta-4 overexpression correlates with high-risk groups in gastric gastrointestinal stromal tumors: A retrospective analysis by immunohistochemistry.
Şahin S; Ekinci O; Seçkin S; Dursun A
Pathol Res Pract; 2017 Sep; 213(9):1139-1143. PubMed ID: 28756979
[TBL] [Abstract][Full Text] [Related]
2. The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors.
Şahin S; Ekinci Ö; Seçkin S; Dursun A
Turk Patoloji Derg; 2017; 33(1):1-8. PubMed ID: 28044310
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of ING4 expression on gastric gastrointestinal stromal tumors by immunohistochemistry.
Sahin S; Ekinci O; Seckin S; Dursun A
Ann Ital Chir; 2017; 88():311-317. PubMed ID: 28566557
[TBL] [Abstract][Full Text] [Related]
4. Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors.
Can B; Karagoz F; Yildiz L; Yildirim A; Kefeli M; Gonullu G; Kandemir B
APMIS; 2012 Sep; 120(9):689-98. PubMed ID: 22882257
[TBL] [Abstract][Full Text] [Related]
5. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal Stromal Tumors: A Clinicopathological and Immunohistochemical Study of 65 Cases.
Tepeoğlu M; Özgün G; Tunca MZ; Tezcaner T; Özdemir BH
Turk Patoloji Derg; 2018; 34(3):207-214. PubMed ID: 29630088
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
8. Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.
Fujita A; Yamamoto H; Imamura M; Nakamura N; Maehara Y; Tsuneyoshi M; Oda Y
Virchows Arch; 2012 Feb; 460(2):163-9. PubMed ID: 22190007
[TBL] [Abstract][Full Text] [Related]
9. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of insulin-growth factor 1 and insulin-growth factor 1 receptor expression in gastrointestinal stromal tumors.
Gu MJ; Bae YK; Choi JH
Hepatogastroenterology; 2013 Sep; 60(126):1383-6. PubMed ID: 24298573
[TBL] [Abstract][Full Text] [Related]
11. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population.
Li J; Zhang H; Chen Z; Su K
Int J Clin Exp Pathol; 2015; 8(12):15969-76. PubMed ID: 26884871
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Outcomes and Prognosis of Elderly Patients (≥ 65 Years) with Gastric Gastrointestinal Stromal Tumors (GISTs) Undergoing Curative-Intent Resection: a Multicenter Data Review.
Yang Z; Feng X; Zhang P; Chen T; Qiu H; Zhou Y; Du C; Yin X; Pan F; Zheng G; Liu X; Huang C; Zhou Z; Li G; Tao K; Li Y
J Gastrointest Surg; 2019 May; 23(5):904-913. PubMed ID: 30324400
[TBL] [Abstract][Full Text] [Related]
14. Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors.
Nanding A; Tang L; Cai L; Chen H; Geng J; Liu X; Ning X; Li X; Zhang Q
Gastric Cancer; 2014 Jan; 17(1):87-96. PubMed ID: 23504291
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
16. Thymosin β4 expression correlates with lymph node metastasis through hypoxia inducible factor-α induction in breast cancer.
Yoon SY; Lee HR; Park Y; Kim JH; Kim SY; Yoon SR; Lee WJ; Cho BJ; Min H; Bang JW; Park H; Bang SI; Cho D
Oncol Rep; 2011 Jan; 25(1):23-31. PubMed ID: 21109953
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and prognosis of mesenteric gastrointestinal stromal tumor: evaluation of a pooled case series.
Feng F; Feng B; Liu S; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
Oncotarget; 2017 Jul; 8(28):46514-46522. PubMed ID: 28147326
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
Cai HX; Li XQ; Wang SF
World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
[TBL] [Abstract][Full Text] [Related]
19. Association of thymosin β4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients.
Wang ZY; Zhang W; Yang JJ; Song DK; Wei JX; Gao S
Neoplasma; 2016; 63(6):991-998. PubMed ID: 27596300
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Gastrointestinal Stromal Tumor: Clinicopathologic Features and Prognosis.
Liu Z; Tian Y; Xu G; Liu S; Guo M; Lian X; Fan D; Zhang H; Feng F
J Clin Gastroenterol; 2017 Oct; 51(9):850-856. PubMed ID: 27673752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]